United States Biotechnology & Medical Research

Apogee Therapeutics Inc (APGE)

Track

Over the last 90 days, Apogee Therapeutics Inc. has seen 35 insider transactions, all of which were sales totaling approximately $38.9 million. Notably, Michael Thomas Henderson, Officer and Director, executed several large proposed and planned sales, amounting to over $23 million. Carl Dambkowski, an Officer, also made proposed sales.

Not featured in screeners

Featured in screeners

Not featured in screeners

Stock chart

Ticker: APGE Exchange: NMS

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

HENDERSON MICHAEL THOMAS

Chief Executive Officer

3 sales — total 300,000 USD

Planned sale 22 Jun 2026

Value US$4,540,466.00 | Price 359.11 | Shares 52,085

Proposed sale 22 Jun 2026

Value US$1,810,101.32 | Price 142.57 | Shares 8,488

Proposed sale 22 Jun 2026

Value US$100,000.00 | Price 132.54 | Shares 1,000

Dambkowski Carl

Chief Medical Officer

1 sale — total 100,000 USD

Planned sale 22 Jun 2026

Value US$4,395,970.04 | Price 217.46 | Shares 67,462

CARL DAMBKOWSKI

Officer

2 sales — total 200,000 USD

Proposed sale 22 Jun 2026

Value US$100,000.00 | Price 90.38 | Shares 1,000

Proposed sale 22 Jun 2026

Value US$100,000.00 | Price 90.38 | Shares 1,000

HENDERSON MICHAEL THOMAS

Chief Executive Officer

11 sales — total 1,100,000 USD

Planned sale 10 Jun 2026

Value US$100,000.00 | Price 86.89 | Shares 1,000

Planned sale 10 Jun 2026

Value US$100,000.00 | Price 86.27 | Shares 1,000

Planned sale 10 Jun 2026

Value US$100,000.00 | Price 85.19 | Shares 1,000

Planned sale 10 Jun 2026

Value US$100,000.00 | Price 84.18 | Shares 1,000

Planned sale 10 Jun 2026

Value US$100,000.00 | Price 82.78 | Shares 1,000

Planned sale 10 Jun 2026

Value US$100,000.00 | Price 86.89 | Shares 1,000

Planned sale 10 Jun 2026

Value US$100,000.00 | Price 86.27 | Shares 1,000

Planned sale 10 Jun 2026

Value US$100,000.00 | Price 85.19 | Shares 1,000

Planned sale 10 Jun 2026

Value US$100,000.00 | Price 84.18 | Shares 1,000

Planned sale 10 Jun 2026

Value US$100,000.00 | Price 82.78 | Shares 1,000

Planned sale 10 Jun 2026

Value US$100,000.00 | Price 82.21 | Shares 1,000

Dambkowski Carl

Chief Medical Officer

1 sale — total 100,000 USD

Planned sale 3 Jun 2026

Value US$100,000.00 | Price 78.71 | Shares 1,000

HENDERSON MICHAEL THOMAS

Chief Executive Officer

3 sales — total 6,589,911 USD

Planned sale 13 May 2026

Value US$110,739.78 | Price 82.58 | Shares 1,341

Planned sale 13 May 2026

Value US$1,530,970.95 | Price 82.05 | Shares 18,659

Proposed sale 13 May 2026

Value US$4,948,200.00 | Price 82.47 | Shares 60,000

Dambkowski Carl

Chief Medical Officer

2 sales — total 462,784 USD

Planned sale 6 May 2026

Value US$152,280.00 | Price 84.60 | Shares 1,800

Planned sale 6 May 2026

Value US$310,504.00 | Price 83.92 | Shares 3,700

CARL DAMBKOWSKI

Officer

1 sale — total 1,832,380 USD

Proposed sale 6 May 2026

Value US$1,832,380.00 | Price 83.29 | Shares 22,000

Henderson Jane

Chief Financial Officer

3 sales — total 164,080 USD

Planned sale 1 May 2026

Value US$24,033.24 | Price 83.16 | Shares 289

Planned sale 1 May 2026

Value US$74,340.00 | Price 82.60 | Shares 900

Planned sale 1 May 2026

Value US$65,707.22 | Price 81.02 | Shares 811

JANE HENDERSON

Officer

1 sale — total 165,780 USD

Proposed sale 1 May 2026

Value US$165,780.00 | Price 82.89 | Shares 2,000

Henderson Jane

Chief Financial Officer

1 sale — total 180,000 USD

Planned sale 16 Apr 2026

Value US$180,000.00 | Price 90.00 | Shares 2,000

HENDERSON MICHAEL THOMAS

Chief Executive Officer

3 sales — total 1,651,664 USD

Planned sale 8 Apr 2026

Value US$17,000.00 | Price 85.00 | Shares 200

Planned sale 8 Apr 2026

Value US$166,520.00 | Price 83.26 | Shares 2,000

Planned sale 8 Apr 2026

Value US$1,468,144.00 | Price 82.48 | Shares 17,800

Dambkowski Carl

Chief Medical Officer

3 sales — total 466,619 USD

Planned sale 1 Apr 2026

Value US$8,589.00 | Price 85.89 | Shares 100

Planned sale 1 Apr 2026

Value US$230,561.66 | Price 85.33 | Shares 2,702

Planned sale 1 Apr 2026

Value US$227,468.38 | Price 84.31 | Shares 2,698

Henderson Jane

Chief Financial Officer

2 sales — total 170,020 USD

Planned sale 1 Apr 2026

Value US$94,006.00 | Price 85.46 | Shares 1,100

Planned sale 1 Apr 2026

Value US$76,014.00 | Price 84.46 | Shares 900

Henderson Jane

Chief Financial Officer

1 sale — total 170,000 USD

Planned sale 25 Mar 2026

Value US$170,000.00 | Price 85.00 | Shares 2,000

JANE HENDERSON

Officer

1 sale — total 438,000 USD

Proposed sale 25 Mar 2026

Value US$438,000.00 | Price 73.00 | Shares 6,000

HENDERSON MICHAEL THOMAS

Chief Executive Officer

3 sales — total 1,495,605 USD

Planned sale 11 Mar 2026

Value US$259,289.48 | Price 75.86 | Shares 3,418

Planned sale 11 Mar 2026

Value US$615,027.77 | Price 74.83 | Shares 8,219

Planned sale 11 Mar 2026

Value US$621,287.27 | Price 74.29 | Shares 8,363

Dambkowski Carl

Chief Medical Officer

3 sales — total 390,825 USD

Planned sale 4 Mar 2026

Value US$14,652.00 | Price 73.26 | Shares 200

Planned sale 4 Mar 2026

Value US$149,358.50 | Price 71.98 | Shares 2,075

Planned sale 4 Mar 2026

Value US$226,814.25 | Price 70.33 | Shares 3,225

Henderson Jane

Chief Financial Officer

4 sales — total 140,431 USD

Planned sale 2 Mar 2026

Value US$29,093.96 | Price 71.66 | Shares 406

Planned sale 2 Mar 2026

Value US$70,027.30 | Price 70.45 | Shares 994

Planned sale 2 Mar 2026

Value US$20,829.00 | Price 69.43 | Shares 300

Planned sale 2 Mar 2026

Value US$20,481.00 | Price 68.27 | Shares 300

HENDERSON MICHAEL THOMAS

Chief Executive Officer

4 sales — total 5,106,953 USD

Planned sale 11 Feb 2026

Value US$62,065.45 | Price 64.99 | Shares 955

Planned sale 11 Feb 2026

Value US$481,225.23 | Price 63.73 | Shares 7,551

Planned sale 11 Feb 2026

Value US$723,662.24 | Price 62.96 | Shares 11,494

Proposed sale 11 Feb 2026

Value US$3,840,000.00 | Price 64.00 | Shares 60,000

Dambkowski Carl

Chief Medical Officer

10 sales — total 723,720 USD

Planned sale 4 Feb 2026

Value US$13,788.00 | Price 68.94 | Shares 200

Planned sale 4 Feb 2026

Value US$6,788.00 | Price 67.88 | Shares 100

Planned sale 4 Feb 2026

Value US$86,838.15 | Price 66.85 | Shares 1,299

Planned sale 4 Feb 2026

Value US$93,478.60 | Price 65.83 | Shares 1,420

Planned sale 4 Feb 2026

Value US$160,967.28 | Price 64.88 | Shares 2,481

Planned sale 4 Feb 2026

Value US$13,788.00 | Price 68.94 | Shares 200

Planned sale 4 Feb 2026

Value US$6,788.00 | Price 67.88 | Shares 100

Planned sale 4 Feb 2026

Value US$86,838.15 | Price 66.85 | Shares 1,299

Planned sale 4 Feb 2026

Value US$93,478.60 | Price 65.83 | Shares 1,420

Planned sale 4 Feb 2026

Value US$160,967.28 | Price 64.88 | Shares 2,481

Henderson Jane

Chief Financial Officer

5 sales — total 211,613 USD

Planned sale 2 Feb 2026

Value US$6,689.00 | Price 66.89 | Shares 100

Planned sale 2 Feb 2026

Value US$73,294.20 | Price 66.15 | Shares 1,108

Planned sale 2 Feb 2026

Value US$6,689.00 | Price 66.89 | Shares 100

Planned sale 2 Feb 2026

Value US$73,294.20 | Price 66.15 | Shares 1,108

Planned sale 2 Feb 2026

Value US$51,646.32 | Price 65.21 | Shares 792

Fairmount Healthcare Fund II L.P.

Director

1 sale — total 133,525,000 USD

Proposed sale 22 Jan 2026

Value US$133,525,000.00 | Price 76.30 | Shares 1,750,000

Fairmount Funds Management LLC

1 sale — total 133,525,000 USD

Sale 22 Jan 2026

Value US$133,525,000.00 | Price 76.30 | Shares 1,750,000

HENDERSON MICHAEL THOMAS

Chief Executive Officer

5 sales — total 1,508,918 USD

Planned sale 14 Jan 2026

Value US$39,381.30 | Price 83.79 | Shares 470

Planned sale 14 Jan 2026

Value US$447,899.76 | Price 83.16 | Shares 5,386

Planned sale 14 Jan 2026

Value US$152,788.14 | Price 82.41 | Shares 1,854

Planned sale 14 Jan 2026

Value US$192,294.00 | Price 81.00 | Shares 2,374

Planned sale 14 Jan 2026

Value US$676,554.32 | Price 79.82 | Shares 8,476

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2026-06-24	2026-06-22	PlS Planned sale	HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director	52,085 -5.2% 359.11 US$4,540,466	52,085 -5.2%	359.11	US$4,540,466
2026-06-24	2026-06-22	PlS Planned sale	Dambkowski Carl Chief Medical Officer Officer	67,462 +34.9% 217.46 US$4,395,970	67,462 +34.9%	217.46	US$4,395,970
2026-06-22	2026-06-22	PrS Proposed sale	HENDERSON MICHAEL THOMAS Officer; Director Executive Director	8,488 142.57 US$1,810,101	8,488	142.57	US$1,810,101
2026-06-22	2026-06-22	PrS Proposed sale	HENDERSON MICHAEL THOMAS Officer; Director Executive Director	1,000 132.54 US$100,000	1,000	132.54	US$100,000
2026-06-22	2026-06-22	PrS Proposed sale	CARL DAMBKOWSKI Officer Officer	1,000 90.38 US$100,000	1,000	90.38	US$100,000
2026-06-22	2026-06-22	PrS Proposed sale	CARL DAMBKOWSKI Officer Officer	1,000 90.38 US$100,000	1,000	90.38	US$100,000
2026-06-12	2026-06-10	PlS Planned sale	HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director	1,000 -0.1% 86.89 US$100,000	1,000 -0.1%	86.89	US$100,000
2026-06-12	2026-06-10	PlS Planned sale	HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director	1,000 -0.2% 86.27 US$100,000	1,000 -0.2%	86.27	US$100,000
2026-06-12	2026-06-10	PlS Planned sale	HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director	1,000 -0.1% 85.19 US$100,000	1,000 -0.1%	85.19	US$100,000
2026-06-12	2026-06-10	PlS Planned sale	HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director	1,000 -0.1% 84.18 US$100,000	1,000 -0.1%	84.18	US$100,000
2026-06-12	2026-06-10	PlS Planned sale	HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director	1,000 -0.7% 82.78 US$100,000	1,000 -0.7%	82.78	US$100,000
2026-06-12	2026-06-10	PlS Planned sale	HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director	1,000 -0.1% 86.89 US$100,000	1,000 -0.1%	86.89	US$100,000
2026-06-12	2026-06-10	PlS Planned sale	HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director	1,000 -0.2% 86.27 US$100,000	1,000 -0.2%	86.27	US$100,000
2026-06-12	2026-06-10	PlS Planned sale	HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director	1,000 -0.1% 85.19 US$100,000	1,000 -0.1%	85.19	US$100,000
2026-06-12	2026-06-10	PlS Planned sale	HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director	1,000 -0.1% 84.18 US$100,000	1,000 -0.1%	84.18	US$100,000
2026-06-12	2026-06-10	PlS Planned sale	HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director	1,000 -0.7% 82.78 US$100,000	1,000 -0.7%	82.78	US$100,000
2026-06-12	2026-06-10	PlS Planned sale	HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director	1,000 -0.6% 82.21 US$100,000	1,000 -0.6%	82.21	US$100,000
2026-06-05	2026-06-03	PlS Planned sale	Dambkowski Carl Chief Medical Officer Officer	1,000 -2.6% 78.71 US$100,000	1,000 -2.6%	78.71	US$100,000
2026-05-15	2026-05-13	PlS Planned sale	HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director	1,341 -0.1% 82.58 US$110,740	1,341 -0.1%	82.58	US$110,740
2026-05-15	2026-05-13	PlS Planned sale	HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director	18,659 -1.6% 82.05 US$1,530,971	18,659 -1.6%	82.05	US$1,530,971
2026-05-13	2026-05-13	PrS Proposed sale	HENDERSON MICHAEL THOMAS Officer; Director Executive Director	60,000 82.47 US$4,948,200	60,000	82.47	US$4,948,200
2026-05-08	2026-05-06	PlS Planned sale	Dambkowski Carl Chief Medical Officer Officer	1,800 -0.9% 84.60 US$152,280	1,800 -0.9%	84.60	US$152,280
2026-05-08	2026-05-06	PlS Planned sale	Dambkowski Carl Chief Medical Officer Officer	3,700 -1.7% 83.92 US$310,504	3,700 -1.7%	83.92	US$310,504
2026-05-06	2026-05-06	PrS Proposed sale	CARL DAMBKOWSKI Officer Officer	22,000 83.29 US$1,832,380	22,000	83.29	US$1,832,380
2026-05-04	2026-05-01	PlS Planned sale	3.6 Henderson Jane Chief Financial Officer Officer	289 -0.2% 83.16 US$24,033	289 -0.2%	83.16	US$24,033
2026-05-04	2026-05-01	PlS Planned sale	3.6 Henderson Jane Chief Financial Officer Officer	900 -0.5% 82.60 US$74,340	900 -0.5%	82.60	US$74,340
2026-05-04	2026-05-01	PlS Planned sale	3.6 Henderson Jane Chief Financial Officer Officer	811 -0.5% 81.02 US$65,707	811 -0.5%	81.02	US$65,707
2026-05-01	2026-05-01	PrS Proposed sale	3.6 JANE HENDERSON Officer Officer	2,000 82.89 US$165,780	2,000	82.89	US$165,780
2026-04-17	2026-04-16	PlS Planned sale	3.6 Henderson Jane Chief Financial Officer Officer	2,000 -1.1% 90.00 US$180,000	2,000 -1.1%	90.00	US$180,000
2026-04-10	2026-04-08	PlS Planned sale	HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director	200 -0.0% 85.00 US$17,000	200 -0.0%	85.00	US$17,000
2026-04-10	2026-04-08	PlS Planned sale	HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director	2,000 -0.2% 83.26 US$166,520	2,000 -0.2%	83.26	US$166,520
2026-04-10	2026-04-08	PlS Planned sale	HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director	17,800 -1.5% 82.48 US$1,468,144	17,800 -1.5%	82.48	US$1,468,144
2026-04-03	2026-04-01	PlS Planned sale	Dambkowski Carl Chief Medical Officer Officer	100 -0.0% 85.89 US$8,589	100 -0.0%	85.89	US$8,589
2026-04-03	2026-04-01	PlS Planned sale	Dambkowski Carl Chief Medical Officer Officer	2,702 -1.3% 85.33 US$230,562	2,702 -1.3%	85.33	US$230,562
2026-04-03	2026-04-01	PlS Planned sale	Dambkowski Carl Chief Medical Officer Officer	2,698 -1.3% 84.31 US$227,468	2,698 -1.3%	84.31	US$227,468
2026-04-03	2026-04-01	PlS Planned sale	3.6 Henderson Jane Chief Financial Officer Officer	1,100 -0.6% 85.46 US$94,006	1,100 -0.6%	85.46	US$94,006
2026-04-03	2026-04-01	PlS Planned sale	3.6 Henderson Jane Chief Financial Officer Officer	900 -0.5% 84.46 US$76,014	900 -0.5%	84.46	US$76,014
2026-03-27	2026-03-25	PlS Planned sale	3.6 Henderson Jane Chief Financial Officer Officer	2,000 -1.1% 85.00 US$170,000	2,000 -1.1%	85.00	US$170,000
2026-03-25	2026-03-25	PrS Proposed sale	3.6 JANE HENDERSON Officer Officer	6,000 73.00 US$438,000	6,000	73.00	US$438,000
2026-03-13	2026-03-11	PlS Planned sale	HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director	3,418 -0.3% 75.86 US$259,289	3,418 -0.3%	75.86	US$259,289
2026-03-13	2026-03-11	PlS Planned sale	HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director	8,219 -0.7% 74.83 US$615,028	8,219 -0.7%	74.83	US$615,028
2026-03-13	2026-03-11	PlS Planned sale	HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director	8,363 -0.7% 74.29 US$621,287	8,363 -0.7%	74.29	US$621,287
2026-03-06	2026-03-04	PlS Planned sale	Dambkowski Carl Chief Medical Officer Officer	200 -0.1% 73.26 US$14,652	200 -0.1%	73.26	US$14,652
2026-03-06	2026-03-04	PlS Planned sale	Dambkowski Carl Chief Medical Officer Officer	2,075 -1.0% 71.98 US$149,358	2,075 -1.0%	71.98	US$149,358
2026-03-06	2026-03-04	PlS Planned sale	Dambkowski Carl Chief Medical Officer Officer	3,225 -1.5% 70.33 US$226,814	3,225 -1.5%	70.33	US$226,814
2026-03-04	2026-03-02	PlS Planned sale	3.6 Henderson Jane Chief Financial Officer Officer	406 -0.2% 71.66 US$29,094	406 -0.2%	71.66	US$29,094
2026-03-04	2026-03-02	PlS Planned sale	3.6 Henderson Jane Chief Financial Officer Officer	994 -0.5% 70.45 US$70,027	994 -0.5%	70.45	US$70,027
2026-03-04	2026-03-02	PlS Planned sale	3.6 Henderson Jane Chief Financial Officer Officer	300 -0.2% 69.43 US$20,829	300 -0.2%	69.43	US$20,829
2026-03-04	2026-03-02	PlS Planned sale	3.6 Henderson Jane Chief Financial Officer Officer	300 -0.2% 68.27 US$20,481	300 -0.2%	68.27	US$20,481
2026-02-13	2026-02-11	PlS Planned sale	HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director	955 -0.1% 64.99 US$62,065	955 -0.1%	64.99	US$62,065
2026-02-13	2026-02-11	PlS Planned sale	HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director	7,551 -0.6% 63.73 US$481,225	7,551 -0.6%	63.73	US$481,225
2026-02-13	2026-02-11	PlS Planned sale	HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director	11,494 -1.0% 62.96 US$723,662	11,494 -1.0%	62.96	US$723,662
2026-02-11	2026-02-11	PrS Proposed sale	HENDERSON MICHAEL THOMAS Officer; Director Executive Director	60,000 64.00 US$3,840,000	60,000	64.00	US$3,840,000
2026-02-04	2026-02-04	PlS Planned sale	Dambkowski Carl Chief Medical Officer Officer	200 -0.1% 68.94 US$13,788	200 -0.1%	68.94	US$13,788
2026-02-04	2026-02-04	PlS Planned sale	Dambkowski Carl Chief Medical Officer Officer	100 -0.0% 67.88 US$6,788	100 -0.0%	67.88	US$6,788
2026-02-04	2026-02-04	PlS Planned sale	Dambkowski Carl Chief Medical Officer Officer	1,299 -0.6% 66.85 US$86,838	1,299 -0.6%	66.85	US$86,838
2026-02-04	2026-02-04	PlS Planned sale	Dambkowski Carl Chief Medical Officer Officer	1,420 -0.7% 65.83 US$93,479	1,420 -0.7%	65.83	US$93,479
2026-02-04	2026-02-04	PlS Planned sale	Dambkowski Carl Chief Medical Officer Officer	2,481 -1.1% 64.88 US$160,967	2,481 -1.1%	64.88	US$160,967
2026-02-04	2026-02-04	PlS Planned sale	Dambkowski Carl Chief Medical Officer Officer	200 -0.1% 68.94 US$13,788	200 -0.1%	68.94	US$13,788
2026-02-04	2026-02-04	PlS Planned sale	Dambkowski Carl Chief Medical Officer Officer	100 -0.0% 67.88 US$6,788	100 -0.0%	67.88	US$6,788
2026-02-04	2026-02-04	PlS Planned sale	Dambkowski Carl Chief Medical Officer Officer	1,299 -0.6% 66.85 US$86,838	1,299 -0.6%	66.85	US$86,838
2026-02-04	2026-02-04	PlS Planned sale	Dambkowski Carl Chief Medical Officer Officer	1,420 -0.7% 65.83 US$93,479	1,420 -0.7%	65.83	US$93,479
2026-02-04	2026-02-04	PlS Planned sale	Dambkowski Carl Chief Medical Officer Officer	2,481 -1.1% 64.88 US$160,967	2,481 -1.1%	64.88	US$160,967
2026-02-04	2026-02-02	PlS Planned sale	3.6 Henderson Jane Chief Financial Officer Officer	100 -0.1% 66.89 US$6,689	100 -0.1%	66.89	US$6,689
2026-02-04	2026-02-02	PlS Planned sale	3.6 Henderson Jane Chief Financial Officer Officer	1,108 -0.6% 66.15 US$73,294	1,108 -0.6%	66.15	US$73,294
2026-02-04	2026-02-02	PlS Planned sale	3.6 Henderson Jane Chief Financial Officer Officer	100 -0.1% 66.89 US$6,689	100 -0.1%	66.89	US$6,689
2026-02-04	2026-02-02	PlS Planned sale	3.6 Henderson Jane Chief Financial Officer Officer	1,108 -0.6% 66.15 US$73,294	1,108 -0.6%	66.15	US$73,294
2026-02-04	2026-02-02	PlS Planned sale	3.6 Henderson Jane Chief Financial Officer Officer	792 -0.4% 65.21 US$51,646	792 -0.4%	65.21	US$51,646
2026-01-22	2026-01-22	PrS Proposed sale	3.5 Fairmount Healthcare Fund II L.P. Director Non-Executive Director	1,750,000 76.30 US$133,525,000	1,750,000	76.30	US$133,525,000
2026-01-22	2026-01-22	S Sale	3.5 Fairmount Funds Management LLC Non-Executive Director	1,750,000 -85.4% 76.30 US$133,525,000	1,750,000 -85.4%	76.30	US$133,525,000
2026-01-16	2026-01-14	PlS Planned sale	HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director	470 -0.0% 83.79 US$39,381	470 -0.0%	83.79	US$39,381
2026-01-16	2026-01-14	PlS Planned sale	HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director	5,386 -0.4% 83.16 US$447,900	5,386 -0.4%	83.16	US$447,900
2026-01-16	2026-01-14	PlS Planned sale	HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director	1,854 -0.2% 82.41 US$152,788	1,854 -0.2%	82.41	US$152,788
2026-01-16	2026-01-14	PlS Planned sale	HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director	2,374 -0.2% 81.00 US$192,294	2,374 -0.2%	81.00	US$192,294
2026-01-16	2026-01-14	PlS Planned sale	HENDERSON MICHAEL THOMAS Chief Executive Officer Executive Director	8,476 -0.7% 79.82 US$676,554	8,476 -0.7%	79.82	US$676,554

Explore more

More insider trading research around Apogee Therapeutics Inc

More insider trades in United States

Similar Healthcare companies with insider activity

More Pharmaceuticals & Medical Research companies with insider activity

More Biotechnology & Medical Research companies with insider activity

Insider trading in North America

Apogee Therapeutics Inc (APGE)

Track

Featured in screeners

Stock chart

Transactions

Insider

Sort by

Trades

Explore more